← Eichor
Study identifier: NCT04404062 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Serological and PCR Testing for COVID-19

Condition: COVID-19  ·  Sponsor: Richmond Research Institute

PhaseN/A
Planned participants2500
Who can joinAll sexes, 5 Years to 70 Years
Healthy volunteersYes

About this study

Richmond Research Institute (RRI) is applying existing and new COVID-19 PCR and antibody tests to help develop methodologies which provide fast and accurate results. Infection with coronavirus (SARS-CoV-2) is currently a worldwide pandemic and reliable testing for COVID-19 is crucial to understand who is infected and therefore a risk to others by spreading the infection. RRI are currently carrying out the following tests: A. Using a membrane-based immunoassay to detect IgG and IgM antibodies to SARS-CoV-2 in whole blood, serum or plasma specimens helps to assess whether an individual has previously had the virus and is potentially immune B. Polymerase Chain Reaction (PCR) testing using an established method to check for active SARS-CoV-2 infections. C. Quantification of anti-SARS-CoV-2 IgG and IgM antibodies in whole blood samples. The above tests are being used by RRI to follow infections (PCR) and immunity (IgG) in their workforce, as well as their families (including children) and visitors to their site. Collecting this data allows the gathering of epidemiological data on SARS-CoV-2 including incidence, prevalence, information on asymptomatic carriers and efficacy of vaccination. Furthermore, identifying individuals that are infected with SARS-CoV-2 has great potential to improve health outcomes by allowing infected individuals to seek the correct medical treatment as well as self-isolate and reduce transmission.

This description comes directly from the study's public registry record.

Talk to the study team

Jorg Taubel, MD  ·  +44(0)2070425800  ·  j.taubel@richmondpharmacology.com

Ulrike Lorch, MD  ·  +44(0)2038482005  ·  u.lorch@richmondpharmacology.com

Always discuss trial participation with your own doctor first.

Locations (1)

Richmond Pharmacology Ltd. 1a Newcomen St, London BridgeLondon, London, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04404062